Keyword: CROs

Plant Construction & Process Technology

Confidentiality is a Potential Pitfall

28.09.2017 - Drug development/manufacturing projects between pharma companies and CDMOs are based on mutual trust and a focus on success. What do the outsourcing partners have to do in order to...

Plant Construction & Process Technology

Consolidation is here to Stay

28.09.2017 - Jane Griffiths: Consolidation in the pharma industry is here to stay: as market competition increases, M&As are one of the fastest ways for companies to obtain critical mass...

Plant Construction & Process Technology

Changes in Portfolios and Pipelines are Likely

28.09.2017 - Will the consolidation in the pharmaceutical industry level off at any time soon or is it here to stay and will even intensify? Marcus Hannakam: We think consolidation will proceed...

Plant Construction & Process Technology

Setting High Standards

28.09.2017 - Drug development/manufacturing projects between pharma companies and CDMOs are based on mutual trust and a focus on success. How big of an issue is a merger or an acquisition for...

Plant Construction & Process Technology

A Partner to Relieve the Strain

28.09.2017 - Will the consolidation in the pharmaceutical industry level off at any time soon or is it here to stay and will it even intensify? Denis Angioletti: Consolidation in the pharma...

Plant Construction & Process Technology

M&A in Pharma and CRO/CMO Industry

28.09.2017 - Challenges caused by a merger or an acquisition can be manifold, no matter whether it is your own organization that is going through M&A and the integration phase or any of your...

Markets & Companies

Bridging the Innovation Gap

02.09.2016 - During the last two decades the pharmaceutical industry was forced to undertake significant structural changes to address mounting challenges from strict regulatory policies, lower...

Strategy & Management

Discovering the Future of Pharma

30.09.2014 - Dramatic changes to the scientific and business environments have made it impossible for pharmaceutical companies to continue operating as they have in the past. A perceived...